Reversal of skin changes in smoldering myeloma with clinical presentation of POEMS syndrome with a lenalidomide-based regimen

Ann Hematol. 2019 Nov;98(11):2625-2626. doi: 10.1007/s00277-019-03818-4. Epub 2019 Oct 25.

Authors

Elena E Solomou¹, Panayiotis Marnellos², Agathoclis Agathokleous³, Georgia Kyriakou⁴, Sophia Georgiou⁴, Argiris Symeonidis⁵

Affiliations

¹ Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, 26500, Rion, Patras, Greece. elenasolomou@hotmail.com.
² American Medical Center, Nicosia, Cyprus.
³ Bank of Cyprus Oncology Center, Nicosia, Cyprus.
⁴ Department of Dermatology, University of Patras Medical School, Rion, Greece.
⁵ Department of Hematology, University of Patras Medical School, Rion, Greece.

PMID: 31650288
DOI: 10.1007/s00277-019-03818-4

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Cyclophosphamide / administration & dosage
Dexamethasone / administration & dosage
Dyspnea / etiology
Edema / etiology
Edema / pathology
Humans
Lenalidomide / administration & dosage
Male
Muscle Weakness / etiology
Nails, Malformed / etiology
POEMS Syndrome / complications
POEMS Syndrome / pathology*
Skin / pathology*
Smoldering Multiple Myeloma / complications
Smoldering Multiple Myeloma / diagnosis
Smoldering Multiple Myeloma / drug therapy
Smoldering Multiple Myeloma / pathology*

Substances

Dexamethasone
Cyclophosphamide
Lenalidomide